| CD4+/CD8+ double-positive T cells: more than just a developmental stage? NH Overgaard, JW Jung, RJ Steptoe, JW Wells Journal of Leucocyte Biology 97 (1), 31-38, 2015 | 321 | 2015 |
| Interleukin‐1β and tumor necrosis factor α inhibit chondrogenesis by human mesenchymal stem cells through NF‐κB–dependent pathways N Wehling, GD Palmer, C Pilapil, F Liu, JW Wells, PE Müller, CH Evans, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 270 | 2009 |
| The role of CXCR3 and its chemokine ligands in skin disease and cancer PT Kuo, Z Zeng, N Salim, S Mattarollo, JW Wells, GR Leggatt Frontiers in medicine 5, 271, 2018 | 155 | 2018 |
| Endocytosis inhibition in humans to improve responses to ADCC-mediating antibodies HY Chew, PO De Lima, JLG Cruz, B Banushi, G Echejoh, L Hu, ... Cell 180 (5), 895-914. e27, 2020 | 128 | 2020 |
| Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage CH Evans, FJ Liu, V Glatt, JA Hoyland, C Kirker-Head, A Walsh, O Betz, ... European cells & materials 18, 96, 2009 | 124 | 2009 |
| Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell–based cancer vaccination J Galea-Lauri, JW Wells, D Darling, P Harrison, F Farzaneh Cancer Immunology, Immunotherapy 53, 963-977, 2004 | 98 | 2004 |
| Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia B Guinn, EA Bland, U Lodi, AP Liggins, K Tobal, S Petters, JW Wells, ... Biochemical and biophysical research communications 335 (4), 1293-1304, 2005 | 96 | 2005 |
| Poly (amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines M Skwarczynski, G Zhao, JC Boer, V Ozberk, A Azuar, JG Cruz, ... Science advances 6 (5), eaax2285, 2020 | 94 | 2020 |
| Regulation of allergic airway inflammation by class I–restricted allergen presentation and CD8 T-cell infiltration JW Wells, CJ Cowled, A Giorgini, DM Kemeny, A Noble Journal of allergy and clinical immunology 119 (1), 226-234, 2007 | 78 | 2007 |
| Cytokines, chemokines, and other biomarkers of response for checkpoint inhibitor therapy in skin cancer JA Bridge, JC Lee, A Daud, JW Wells, JA Bluestone Frontiers in medicine 5, 351, 2018 | 77 | 2018 |
| Combined triggering of dendritic cell receptors results in synergistic activation and potent cytotoxic immunity JW Wells, CJ Cowled, F Farzaneh, A Noble The Journal of Immunology 181 (5), 3422-3431, 2008 | 74 | 2008 |
| Inflammatory cytokines induce a unique mineralizing phenotype in mesenchymal stem cells derived from human bone marrow E Ferreira, RM Porter, N Wehling, RP O'Sullivan, F Liu, A Boskey, ... Journal of Biological Chemistry 288 (41), 29494-29505, 2013 | 69 | 2013 |
| HPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2-and CCL5-mediated recruitment of mast cells AS Bergot, N Ford, GR Leggatt, JW Wells, IH Frazer, MA Grimbaldeston PLoS pathogens 10 (10), e1004466, 2014 | 67 | 2014 |
| Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial AH Forster, K Witham, ACI Depelsenaire, M Veitch, JW Wells, A Wheatley, ... PLoS Medicine 17 (3), e1003024, 2020 | 62 | 2020 |
| Evolution of cancer vaccines—Challenges, achievements, and future directions BQ Tay, Q Wright, R Ladwa, C Perry, G Leggatt, F Simpson, JW Wells, ... Vaccines 9 (5), 535, 2021 | 57 | 2021 |
| DNA vaccine encoding HPV16 oncogenes E6 and E7 induces potent cell-mediated and humoral immunity which protects in tumor challenge and drives E7-expressing skin graft rejection J Chandra, JL Dutton, B Li, WP Woo, Y Xu, LK Tolley, M Yong, JW Wells, ... Journal of Immunotherapy 40 (2), 62-70, 2017 | 54 | 2017 |
| Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma HR Keller, X Zhang, L Li, H Schaider, JW Wells Oncotarget 8 (43), 75675, 2017 | 53 | 2017 |
| Does the nature of residual immune function explain the differential risk of non‐melanoma skin cancer development in immunosuppressed organ transplant recipients? JW Jung, NH Overgaard, MT Burke, N Isbel, IH Frazer, F Simpson, ... International journal of cancer 138 (2), 281-292, 2016 | 53 | 2016 |
| EWS-FLI-1-targeted cytotoxic T-cell killing of multiple tumor types belonging to the Ewing sarcoma family of tumors CH Evans, F Liu, RM Porter, RP O'Sullivan, T Merghoub, EP Lunsford, ... Clinical Cancer Research 18 (19), 5341-5351, 2012 | 50 | 2012 |
| Rapid and reliable healing of critical size bone defects with genetically modified sheep muscle F Liu, E Ferreira, RM Porter, V Glatt, M Schinhan, Z Shen, MA Randolph, ... European cells & materials 30, 118, 2015 | 49 | 2015 |
Ian FrazerThe University of Queensland在 uq.edu.au 的电子邮件经过验证
